9.61

3.11% 0.29

Pre-market: 9.61

Ginkgo Bioworks Holdings Inc (DNA)

Overview News Price History Option Chain Why DNA Down? Discussions Forecast

Ginkgo Bioworks Holdings Inc stock is traded at $9.61, with a volume of 1.15M. It is up +3.11% in the last 24 hours and up +37.48% over the past month. Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering: where company provide biological R&D services for customers across a range of industries and Biosecurity: where it provide services to government and commercial customers to identify, monitor, prevent, mitigate, and ultimately protect humanity from biological threats. The maximum of revenue is from Cell Engineering Segment.

Previous Close:

$9.32

Open:

$9.33

24h Volume:

1.15M

Relative Volume:

0.96

Market Cap:

$497.52M

Revenue:

$217.11M

Net Income/Loss:

$-651.19M

P/E Ratio:

-0.7398

EPS:

-12.99

Net Cash Flow:

$-387.26M

1W Performance:

+12.00%

1M Performance:

+37.48%

6M Performance:

-5.97%

1Y Performance:

-15.38%

1-Day Range:

$9.1001

$9.84

1-Week Range:

$8.21

$9.84

52-Week Range:

$5.00

$16.85

Ginkgo Bioworks Holdings Inc Stock (DNA) Company Profile

Name

Ginkgo Bioworks Holdings Inc

Sector

Healthcare (1170)

Industry

Biotechnology (661)

Phone

(877) 442-5362

Address

27 DRYDOCK AVENUE, BOSTON

Employee

834

Twitter

Next Earnings Date

2024-08-08

Latest SEC Filings

DNA's Discussions on Twitter

Compare DNA with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
DNA Ginkgo Bioworks Holdings Inc	9.61	497.52M	217.11M	-651.19M	-387.26M	-12.99
VRTX Vertex Pharmaceuticals Inc	443.40	115.95B	11.10B	-988.90M	-1.26B	-3.92
REGN Regeneron Pharmaceuticals Inc	521.00	56.52B	14.09B	4.50B	2.96B	39.28
ALNY Alnylam Pharmaceuticals Inc	318.25	39.44B	2.35B	-269.70M	-75.39M	-2.09
ARGX Argen X Se Adr	560.04	35.14B	2.58B	1.06B	-1.28B	16.33
ONC Beone Medicines Ltd Adr	254.49	28.51B	3.81B	-644.79M	-669.77M	-6.24

Ginkgo Bioworks Holdings Inc Stock (DNA) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
May-15-24	Downgrade	BTIG Research	Neutral → Sell
May-10-24	Downgrade	William Blair	Mkt Perform → Underperform
Nov-14-23	Downgrade	Raymond James	Outperform → Mkt Perform
Nov-09-23	Downgrade	BTIG Research	Buy → Neutral
Jun-02-23	Downgrade	Goldman	Neutral → Sell
May-11-23	Downgrade	William Blair	Outperform → Mkt Perform
Nov-29-22	Initiated	Berenberg	Buy
Oct-04-22	Initiated	Morgan Stanley	Equal-Weight
May-18-22	Downgrade	BofA Securities	Neutral → Underperform
Mar-02-22	Resumed	Cowen	Outperform
Feb-23-22	Initiated	Goldman	Neutral
Feb-01-22	Initiated	BofA Securities	Neutral
Jan-28-22	Initiated	BofA Securities	Buy
Jan-07-22	Initiated	BTIG Research	Buy
Nov-29-21	Initiated	Jefferies	Buy
Oct-13-21	Initiated	Raymond James	Outperform
Oct-12-21	Initiated	William Blair	Outperform
Sep-20-21	Initiated	HSBC Securities	Buy

View All

Ginkgo Bioworks Holdings Inc Stock (DNA) Latest News

Jun 18, 2025

Lobbying Update: $10,000 of GINKGO BIOWORKS lobbying was just disclosed - Nasdaq

Jun 18, 2025

Jun 13, 2025

Ginkgo Bioworks Holds Annual Shareholder Meeting, Elects Directors - TipRanks

Jun 13, 2025

Jun 12, 2025

5 "Best" Publicly Traded Synthetic Biology Companies - Securities.io

Jun 12, 2025

Jun 11, 2025

Ginkgo Bioworks (DNA) Sees 5.4% Increase in Stock Price | DNA Stock News - GuruFocus

Jun 11, 2025

Jun 09, 2025

Where are the Opportunities in (DNA) - news.stocktradersdaily.com

Jun 09, 2025

Jun 06, 2025

Ginkgo Bioworks: Hedge Funds Pull Back and Other Important Updates - TradingView

Jun 06, 2025

Squarepoint Ops LLC Has $417,000 Stock Holdings in Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) - Defense World

Jun 06, 2025

Jun 04, 2025

From Promise to Peril: The Downfall of Ginkgo Bioworks - TradingView

Jun 04, 2025